ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Q: What does CUSIP H0036K147 represent in this 13F holders report?

CUSIP H0036K147 is the security identifier for ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share used to aggregate holder disclosures.

Q: How many institutions held ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in Q2 2021?

53 institutional investors reported ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: H0036K147

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Shares, par value CHF 0.08 per share
Shares outstanding: 128,210,515
Total 13F shares: 33,533,099
Share change: +707,041
Total reported value: $816,251,800
Put/Call ratio: 20%
Price per share: $24.35
Number of holders: 53
Value change: +$17,173,667
Number of buys: 28
Number of sells: 20

Quarterly Holders Quick Answers

What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP H0036K147:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	6.1%	7,761,585	$189,460,000	—	31 Mar 2021	13F
Redmile Group, LLC	13F	Company	5.7%	7,308,418	$178,398,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	2.5%	3,142,253	$76,702,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.1%	2,745,794	$67,025,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	2.1%	2,630,491	$64,210,000	—	31 Mar 2021	13F
Vantage Consulting Group Inc	13F	Company	1.3%	1,680,149	$41,012,000	—	31 Mar 2021	13F
Grosvenor Holdings, L.L.C.	13F	Company	1.2%	1,517,212	$37,035,000	—	31 Mar 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	1.1%	1,418,107	$34,616,000	—	31 Mar 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.71%	914,739	$22,329,000	—	31 Mar 2021	13F
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC	13F	Company	0.47%	607,800	$14,836,000	—	31 Mar 2021	13F
HHLR ADVISORS, LTD.	13F	Company	0.39%	500,000	$12,205,000	—	31 Mar 2021	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.3%	379,137	$9,255,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	0.18%	233,854	$5,709,000	—	31 Mar 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.17%	219,499	$5,358,000	—	31 Mar 2021	13F
MPM BioImpact LLC	13F	Company	0.17%	218,027	$5,322,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.16%	204,227	$4,985,000	—	31 Mar 2021	13F
Employees Retirement System of Texas	13F	Company	0.11%	135,000	$3,295,000	—	31 Mar 2021	13F
Burrage Capital Management LLC	13F	Company	0.1%	124,875	$3,048,000	—	31 Mar 2021	13F
Magnetar Financial LLC	13F	Company	0.09%	110,198	$2,690,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	99,288	$2,424,000	—	31 Mar 2021	13F
Indie Asset Partners, LLC	13F	Company	0.07%	92,116	$2,249,000	—	31 Mar 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.07%	84,290	$2,058,000	—	31 Mar 2021	13F
Caption Management, LLC	13F	Company	0.06%	83,000	$2,026,000	—	31 Mar 2021	13F
Rockefeller Capital Management L.P.	13F	Company	0.06%	79,397	$1,938,000	—	31 Mar 2021	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.06%	78,137	$1,907,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.06%	73,925	$1,805,000	—	31 Mar 2021	13F
Allianz Asset Management GmbH	13F	Company	0.05%	62,590	$1,528,000	—	31 Mar 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.05%	61,419	$1,500,000	—	31 Mar 2021	13F
BAILARD, INC.	13F	Company	0.04%	56,000	$1,367,000	—	31 Mar 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.03%	32,774	$800,000	—	31 Mar 2021	13F
PEAK6 Investments LLC	13F	Company	0.02%	31,912	$779,000	—	31 Mar 2021	13F
Zurcher Kantonalbank (Zurich Cantonalbank)	13F	Company	0.02%	21,408	$523,000	—	31 Mar 2021	13F
MONETA GROUP INVESTMENT ADVISORS LLC	13F	Company	0.02%	19,500	$476,000	—	31 Mar 2021	13F
AlphaCentric Advisors LLC	13F	Company	0.01%	17,000	$415,000	—	31 Mar 2021	13F
CNA FINANCIAL CORP	13F	Company	0.01%	15,686	$383,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	15,162	$370,000	—	31 Mar 2021	13F
Henry James International Management Inc.	13F	Company	0.01%	15,009	$366,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	13,879	$339,000	—	31 Mar 2021	13F
VIRTUS ADVISERS, LLC	13F	Company	0.01%	8,776	$214,000	—	31 Mar 2021	13F
SG Americas Securities, LLC	13F	Company	0%	5,000	$122,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	2,200	$54,000	—	31 Mar 2021	13F
US BANCORP \DE\	13F	Company	0%	1,800	$44,000	—	31 Mar 2021	13F
Cantonale Vaudoise Banque	13F	Individual	0%	1,000	$24,000	—	31 Mar 2021	13F
SIMPLEX TRADING, LLC	13F	Company	0%	936	$22,000	—	31 Mar 2021	13F
State of Wyoming	13F	Company	0%	875	$21,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	427	$11,000	—	31 Mar 2021	13F
GROUP ONE TRADING LLC	13F	Company	0%	200	$5,000	—	31 Mar 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	181	$5,000	—	31 Mar 2021	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0%	200	$4,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0%	157	$4,000	—	31 Mar 2021	13F

Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q2 2021

As of 30 Jun 2021, ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,533,099 shares. The largest 10 holders included FMR LLC, Redmile Group, LLC, JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., PRICE T ROWE ASSOCIATES INC /MD/, Vantage Consulting Group Inc, Grosvenor Holdings, L.L.C., BAKER BROS. ADVISORS LP, EVENTIDE ASSET MANAGEMENT, LLC, and HHLR ADVISORS, LTD.. This page lists 53 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

-2

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.